SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-055687
Filing Date
2021-02-25
Accepted
2021-02-25 07:07:54
Documents
13
Period of Report
2021-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d118084d8k.htm   iXBRL 8-K 25265
2 EX-99.1 d118084dex991.htm EX-99.1 136508
  Complete submission text file 0001193125-21-055687.txt   307027

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mrna-20210225.xsd EX-101.SCH 3072
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrna-20210225_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrna-20210225_pre.xml EX-101.PRE 10954
6 EXTRACTED XBRL INSTANCE DOCUMENT d118084d8k_htm.xml XML 3228
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38753 | Film No.: 21676373
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences